Suppr超能文献

两种肥大细胞稳定剂和维拉帕米对大鼠胃酸分泌的体外作用。

The action of two mast cell stabilising agents and verapamil on rat gastric acid secretion in vitro.

作者信息

Canfield P, Coruzzi G, Curwain B, Rundell T

出版信息

Eur J Pharmacol. 1985 Oct 8;116(1-2):89-95. doi: 10.1016/0014-2999(85)90188-8.

Abstract

The actions of two mast cell stabilising agents, FPL 52694 and disodium cromoglycate and the Ca2+ channel antagonist verapamil on acid secretion by the rat isolated stomach have been studied. FPL 52694 (1-5 mM) in the serosal medium stimulated acid secretion. This was antagonised by prostaglandin E2 but not by atropine, metiamide, propranolol or tetrodotoxin. FPL 52694 (1-5 mM) in the mucosal medium had an inhibitory effect on basal acid secretion and that stimulated by pentagastrin and histamine. The inhibition reversed only slowly after removal of FPL 52694. Disodium cromoglycate and serosal application of verapamil had no significant effects on acid output. Removal of calcium from the bathing solutions and mucosal verapamil inhibited basal secretion. Topically applied, FPL 52694 is a potent inhibitor of acid secretion in vitro. This effect may involve an action upon the availability of calcium to the tissue. The stimulatory effects of serosal FPL 52694 are discussed in relation to previous in vivo findings.

摘要

研究了两种肥大细胞稳定剂FPL 52694和色甘酸钠以及钙通道拮抗剂维拉帕米对大鼠离体胃泌酸的作用。浆膜介质中的FPL 52694(1 - 5 mM)刺激胃酸分泌。这种作用被前列腺素E2拮抗,但不受阿托品、甲硫咪特、普萘洛尔或河豚毒素拮抗。粘膜介质中的FPL 52694(1 - 5 mM)对基础胃酸分泌以及五肽胃泌素和组胺刺激的胃酸分泌有抑制作用。去除FPL 52694后,抑制作用仅缓慢逆转。色甘酸钠和浆膜应用维拉帕米对胃酸分泌无显著影响。从浴液中去除钙和粘膜应用维拉帕米抑制基础分泌。局部应用时,FPL 52694在体外是一种有效的胃酸分泌抑制剂。这种作用可能涉及对组织钙可用性的影响。结合先前的体内研究结果讨论了浆膜FPL 52694的刺激作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验